Clinical Trials Directory

Trials / Completed

CompletedNCT02178137

Effect of Interventions on the Progression of Knee Osteoarthritis

Effect of Interventions on Progression of Knee Osteoarthritis - a Comparison of Effect of Glucosamine/Chondroitin or Diacerin Vs Placebo: Measured by Clinical, Radiological and Biochemical Parameters

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
322 (actual)
Sponsor
Indus Hospital and Health Network · Academic / Other
Sex
All
Age
40 Years – 65 Years
Healthy volunteers
Not accepted

Summary

There has been intensive search for a substance that can have disease-modifying activity for osteoarthritis. A number of medications have been reported to be of benefit on slowing progression of knee OA. This trial will be the first head to head comparison of these medications. Patients aged between age 40 to 65 will be enrolled. Patients will be assessed clinically using two scoring systems, the WOMAC index for knee arthritis and the SF 36 for overall physical and mental health. The knee X rays will be assessed on Kellgren and Lawrence grading and will also be measured for joint space narrowing at follow up. The response to arthritis medications on slowing down cartilage loss will be measured biochemically with COMP levels.

Conditions

Interventions

TypeNameDescription
DRUGDiacerien
DRUGGlucosamine/Chondroitin
DRUGPlacebo

Timeline

Start date
2014-06-01
Primary completion
2017-09-01
Completion
2017-10-01
First posted
2014-06-30
Last updated
2018-03-01

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT02178137. Inclusion in this directory is not an endorsement.